EGFR and neoplasm: They can be further categorized into three types according to the difference in the signals they block: (i) simultaneous targeting of two surface receptors with specific signaling and functional overlap associated with tumorigenesis and progression, mainly ErbB family proteins; (ii) dual immune checkpoint molecule blockade; (iii) simultaneous inhibition of immune checkpoints and tumor microenvironmental pro-tumor growth factors.